Skip to main content
Primary Care Respiratory Journal: Journal of the General Practice Airways Group logoLink to Primary Care Respiratory Journal: Journal of the General Practice Airways Group
. 2009 Jan 14;18(3):171–176. doi: 10.3132/pcrj.2009.00003

Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial

Niels H Chavannesa 1,2,*, Marlous Grijsen 2, Marjan van den Akker 2, Huub Schepers 3, Maddy Nijdam 3, Brian Tiep 4, Jean Muris 2
PMCID: PMC6619261  PMID: 19142557

Abstract

Aim:

To assess the long-term effectiveness of an integrated disease management (IDM) program (consisting of optimal medication, reactivation, education, and exacerbation management) in primary care patients with chronic obstructive pulmonary disease (COPD).

Method:

Controlled trial comparing the effects of IDM on quality of life — assessed by the St. George's Respiratory Questionnaire (SGRQ) — in primary care COPD patients. The minimal clinically important change on the SGRQ was accepted as being −4 points. Baseline and one-year differences were compared using paired sample T-tests. The differential effects of an FEV1/FVC ratio <0.7 and dyspnoea as assessed by the Medical Research Council (MRC) Dyspnoea scale were investigated.

Results:

The average age of subjects was 63 years, with an average post-bronchodilator FEV1 of 67% predicted, average FEV1/FVC ratio of 0.65, a mean of 35 pack-years smoking, and 63% were male. No significant differences existed between groups at baseline. After one year of IDM, SGRQ had improved by −4.6 points (95% CI, −7.2 to −2.0; p=0.001) in the intervention group, versus −0.7 points (95% CI, −3.0 to 1.6; p=0.6) in the usual care group. In patients with an FEV1/FVC ratio <0.7, SGRQ improved by −5.9 points (95% CI, −9.6 to −2.2; p=0.002) in the IDM group, while in the usual care group SGRQ improved by −0.8 points (95% CI, −4.1 to 2.4; p=0.6). In patients with an MRC Dyspnoea score >2 and FEV1/FVC <0.7, SGRQ improved by −13.4 points (95% CI, −20.8 to −6.1; p=0.002) in the IDM group, versus −0.3 points (95% CI, −5.5 to 4.9; p=0.9) in the usual care group.

Conclusion:

In this study, IDM improved one-year quality of life in primary care COPD patients, compared to usual care. The improvement in SGRQ was both clinically relevant and statistically significant, and was greatest in patients with FEV1/FVC <0.7 and MRC Dyspnoea score >2.

Keywords: COPD, quality of life, questionnaire, SGRQ, FEV1/FVC ratio, MRC Dyspnoea score

Full Text

The Full Text of this article is available as a PDF (493.8 KB).

Footnotes

All authors declare that they have no conflict of interest with regard to this study.


Articles from Primary Care Respiratory Journal: Journal of the General Practice Airways Group are provided here courtesy of Primary Care Respiratory Society UK/Macmillan Publishers Limited

RESOURCES